Vor Biopharma Announces Pricing of Initial Public Offering
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Vor Biopharma Announces Pricing of Initial Public Offering Vor BiopharmaFebruary 5, 2021 GMT CAMBRIDGE, Mass., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced the pricing of its initial public offering of 9,828,017 shares of its common stock at a price to the public of $18.00 per share. The gross proceeds to Vor from the of...
Source: apnews.com